Cargando…
Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
BACKGROUND: Given the growth in dense breast notification (DBN) legislation in the United States, we examined the association between different types of DBN laws and supplemental screening behaviors among women. METHODS: We surveyed in March–April 2018 a nationally representative sample of women age...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402830/ https://www.ncbi.nlm.nih.gov/pubmed/32537899 http://dx.doi.org/10.1002/cam4.3218 |
_version_ | 1783566833129881600 |
---|---|
author | Aminawung, Jenerius A. Hoag, Jessica R. Kyanko, Kelly A. Xu, Xiao Richman, Ilana B. Busch, Susan H. Gross, Cary P. |
author_facet | Aminawung, Jenerius A. Hoag, Jessica R. Kyanko, Kelly A. Xu, Xiao Richman, Ilana B. Busch, Susan H. Gross, Cary P. |
author_sort | Aminawung, Jenerius A. |
collection | PubMed |
description | BACKGROUND: Given the growth in dense breast notification (DBN) legislation in the United States, we examined the association between different types of DBN laws and supplemental screening behaviors among women. METHODS: We surveyed in March–April 2018 a nationally representative sample of women aged 40‐59 years who received a routine screening mammogram in the past 18 months. Survey items included the following topics regarding supplemental screening: discussing risks or benefits with a provider, knowledge about the risk of false positives, and utilization. We grouped women by state DBN into non‐DBN, generic DBN (mentions breast density but not supplemental screening), DBN that mentions supplemental screening (DBN‐SS), and DBN with mandated insurance coverage for supplemental screening (DBN‐coverage), and estimated adjusted predicted probabilities for supplemental screening behaviors. RESULTS: Of 1641 women surveyed, 21.3% resided in non‐DBN, 41.2% in generic DBN, 25.8% in DBN‐SS, and 12.5% in DBN‐coverage states. Overall, 23.0% of respondents had discussed supplemental screening with a provider, 11.3% of whom discussed the risks, and 49.5% discussed the benefits. In adjusted analysis, women living in DBN‐coverage states were more likely to discuss supplemental screening (27.5%) than women in non‐DBN states (13.6%); pairwise contrast 13.8% (95% CI, 2.1% to 25.6%; P = .01). They were also more likely to have received supplemental screening for increased breast density (19.3%) compared to women living in non‐DBN (9.9%); contrast 9.4% (95% CI, 1.6% to 17.3%; P = .01), Generic DBN (7.3%); difference 12.0% (95% CI, 4.6% to 19.4%; P =< .001), and DBN‐SS (8.8%); contrast 10.5% (95% CI, 2.6% to 18.5%; P < .01) states. CONCLUSIONS: Women in DBN‐coverage states were more likely to discuss supplemental screening with their providers, and to undergo supplemental screening, compared to women in states with other types of DBN laws, or without DBN laws. |
format | Online Article Text |
id | pubmed-7402830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74028302020-08-06 Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation Aminawung, Jenerius A. Hoag, Jessica R. Kyanko, Kelly A. Xu, Xiao Richman, Ilana B. Busch, Susan H. Gross, Cary P. Cancer Med Cancer Prevention BACKGROUND: Given the growth in dense breast notification (DBN) legislation in the United States, we examined the association between different types of DBN laws and supplemental screening behaviors among women. METHODS: We surveyed in March–April 2018 a nationally representative sample of women aged 40‐59 years who received a routine screening mammogram in the past 18 months. Survey items included the following topics regarding supplemental screening: discussing risks or benefits with a provider, knowledge about the risk of false positives, and utilization. We grouped women by state DBN into non‐DBN, generic DBN (mentions breast density but not supplemental screening), DBN that mentions supplemental screening (DBN‐SS), and DBN with mandated insurance coverage for supplemental screening (DBN‐coverage), and estimated adjusted predicted probabilities for supplemental screening behaviors. RESULTS: Of 1641 women surveyed, 21.3% resided in non‐DBN, 41.2% in generic DBN, 25.8% in DBN‐SS, and 12.5% in DBN‐coverage states. Overall, 23.0% of respondents had discussed supplemental screening with a provider, 11.3% of whom discussed the risks, and 49.5% discussed the benefits. In adjusted analysis, women living in DBN‐coverage states were more likely to discuss supplemental screening (27.5%) than women in non‐DBN states (13.6%); pairwise contrast 13.8% (95% CI, 2.1% to 25.6%; P = .01). They were also more likely to have received supplemental screening for increased breast density (19.3%) compared to women living in non‐DBN (9.9%); contrast 9.4% (95% CI, 1.6% to 17.3%; P = .01), Generic DBN (7.3%); difference 12.0% (95% CI, 4.6% to 19.4%; P =< .001), and DBN‐SS (8.8%); contrast 10.5% (95% CI, 2.6% to 18.5%; P < .01) states. CONCLUSIONS: Women in DBN‐coverage states were more likely to discuss supplemental screening with their providers, and to undergo supplemental screening, compared to women in states with other types of DBN laws, or without DBN laws. John Wiley and Sons Inc. 2020-06-14 /pmc/articles/PMC7402830/ /pubmed/32537899 http://dx.doi.org/10.1002/cam4.3218 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Prevention Aminawung, Jenerius A. Hoag, Jessica R. Kyanko, Kelly A. Xu, Xiao Richman, Ilana B. Busch, Susan H. Gross, Cary P. Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation |
title | Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation |
title_full | Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation |
title_fullStr | Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation |
title_full_unstemmed | Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation |
title_short | Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation |
title_sort | breast cancer supplemental screening: women’s knowledge and utilization in the era of dense breast legislation |
topic | Cancer Prevention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402830/ https://www.ncbi.nlm.nih.gov/pubmed/32537899 http://dx.doi.org/10.1002/cam4.3218 |
work_keys_str_mv | AT aminawungjeneriusa breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation AT hoagjessicar breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation AT kyankokellya breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation AT xuxiao breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation AT richmanilanab breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation AT buschsusanh breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation AT grosscaryp breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation |